ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Brentjens et al.
Papers
Science Translational Medicine
March 2013
Authors and Affiliates
Brentjens RJ1, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M. 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.